CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL

03.01.25 21:45 Uhr

Werte in diesem Artikel
Aktien

20,80 EUR -2,00 EUR -8,77%

HOUSTON, Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on January 30, 2025.  

Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results.  An earnings press release will be issued after market close on January 29, 2025 and may be accessed through the Company's website at www.corelab.com.

To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call.  For those not available to listen to the live webcast, a replay and transcript will be available on the Company's website shortly after the call.

For conference call information, please contact Jenna Palfrey at jenna.palfrey@corelab.com for the dial-in number.

Core Laboratories Inc. (www.corelab.com) is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.  The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world.

Core Laboratories logo (PRNewsFoto/Core Laboratories) (PRNewsfoto/Core Laboratories)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/core-laboratories-announces-timing-of-fourth-quarter-2024-earnings-release-and-conference-call-302342143.html

SOURCE Core Laboratories Inc

Ausgewählte Hebelprodukte auf Core Laboratories NV

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Core Laboratories NV

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Core Laboratories NV

Wer­bung

Analysen zu Core Laboratories NV

DatumRatingAnalyst
29.10.2018Core Laboratories NV Market PerformCowen and Company, LLC
10.10.2018Core Laboratories NV UnderperformWolfe Research
07.09.2017Core Laboratories NV OutperformRBC Capital Markets
21.04.2017Core Laboratories NV BuyLoop Capital
13.12.2016Core Laboratories NV NeutralUBS AG
DatumRatingAnalyst
07.09.2017Core Laboratories NV OutperformRBC Capital Markets
21.04.2017Core Laboratories NV BuyLoop Capital
22.04.2016Core Laboratories NV OutperformRBC Capital Markets
28.01.2016Core Laboratories NV OutperformRBC Capital Markets
18.09.2015Core Laboratories NV OutperformRBC Capital Markets
DatumRatingAnalyst
29.10.2018Core Laboratories NV Market PerformCowen and Company, LLC
13.12.2016Core Laboratories NV NeutralUBS AG
22.04.2016Core Laboratories NV Market PerformCowen and Company, LLC
12.01.2016Core Laboratories NV PerformOppenheimer & Co. Inc.
26.10.2015Core Laboratories NV Market PerformCowen and Company, LLC
DatumRatingAnalyst
10.10.2018Core Laboratories NV UnderperformWolfe Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Core Laboratories NV nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"